Accent Microcell (NSE:ACCENTMIC) ROC %: 21.63% (As of Mar. 2025)


NSE:ACCENTMIC Accent Microcell Ltd NSE:ACCENTMIC
19 GF Score
Price ₹485.25
! 6 Warning Signs
View Full Analysis

What is Accent Microcell ROC %?

Accent Microcell NSE:ACCENTMIC +0.32% 19 ROC % is 21.63% as of Mar. 2025. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 19/100. The stock has 6 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Accent Microcell's annualized return on capital (ROC %) for the quarter that ended in Mar. 2025 was 21.63%.

As of today (2026-07-01), Accent Microcell's WACC % is 12.95%. Accent Microcell's ROC % is 21.63% (calculated using TTM income statement data). Accent Microcell generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Accent Microcell  (NSE:ACCENTMIC) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Accent Microcell's WACC % is 12.95%. Accent Microcell's ROC % is 21.63% (calculated using TTM income statement data). Accent Microcell generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Accent Microcell ROC % Related Terms


Accent Microcell ROC % Historical Data

* Premium members only.

The historical data trend for Accent Microcell's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accent Microcell ROC % Chart

Accent Microcell Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
ROC %
11.76 11.73 18.39 32.64 21.63

Accent Microcell Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Mar25
ROC % 11.76 11.73 18.39 32.64 21.63
NSE:ACCENTMIC
19GF Score
Accent Microcell Ltd NSE:ACCENTMIC
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accent Microcell ROC % Calculation

Accent Microcell's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2025 is calculated as:

ROC % (A: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2024 ) + Invested Capital (A: Mar. 2025 ))/ count )
=385.489 * ( 1 - 24.44% )/( (1118.526 + 1575.205)/ 2 )
=291.2754884/1346.8655
=21.63 %

where

Invested Capital(A: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2048.397 - 206.431 - ( 723.44 - max(0, 378.58 - 1634.42+723.44))
=1118.526

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2283.744 - 198.405 - ( 510.134 - max(0, 303.931 - 1543.554+510.134))
=1575.205

Accent Microcell's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2025 is calculated as:

ROC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=385.489 * ( 1 - 24.44% )/( (1118.526 + 1575.205)/ 2 )
=291.2754884/1346.8655
=21.63 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2048.397 - 206.431 - ( 723.44 - max(0, 378.58 - 1634.42+723.44))
=1118.526

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2283.744 - 198.405 - ( 510.134 - max(0, 303.931 - 1543.554+510.134))
=1575.205

Note: The Operating Income data used here is one times the annual (Mar. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 21.63% mean?
Accent Microcell (NSE:ACCENTMIC) has a ROC % of 21.63% as of Mar. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Accent Microcell and its competitors.
Is Accent Microcell's ROC % too high?
Accent Microcell's current ROC % is 21.63%. The Drug Manufacturers industry median ROC % is 4.51. Accent Microcell's value of 21.63% is 379.6% above this industry median. Overall, Accent Microcell has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's ROC % compare to ZTS and UTHR?
Accent Microcell's ROC % of 21.63% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.51. Accent Microcell's value of 21.63% is 379.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.51, based on 983 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current ROC % of 21.63% is 379.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current ROC % is 21.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current ROC % of 21.63%. The current ROC % is 21.63% and 379.6% above the Drug Manufacturers industry median of 4.51. Accent Microcell's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current ROC % is 21.63% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accent Microcell Business Description

Address Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
19GF Score

Get the complete analysis for NSE:ACCENTMIC

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹485.25
Price